Exploration on improvement of the compliance of colorectal cancer screening in Wujing community of Shanghai / 上海预防医学

To explore the model and method of improving the compliance of colorectal cancer screening , especially the fine sieve compliance of colonoscopy . [ Methods ] The colorectal cancer screening in Wujing community was led by Wujing Community Health Center .For the sake of impro-ving the compliance of screening , Wujing Community Health Center established a screening team and speci-fied a neighboring general hospital as screening partner .We also used the method of refining the screening steps , tracking the result in time , simplifying the procedures of colonoscopy test and making epidemiological analysis. [Results] From October 1,2012 to September 30,2013, a total of 7 507 people in Wujing community received colorectal cancer screening , of whom 427 (5.69%) were found to be positive in fecal occult blood testing (FOBT).And among them, 386 (90.40%) agreed to accept the colonoscopy test and finally 380 people (88.90%) finished the test.According to the results of colonoscopy test were detected 5 cancer patients (1.32%) and 84 precancerous lesion patients (22.11%).Further treatment rate for color-ectal cancer patients was 100.00%and for precancerous lesion patients 75.00%.The median duration was 4 days for preliminary screening positive subjects from preliminary screening to receiving positive notification and 10 days for refined screening .The median duration was 3 days for colorectal cancer patients from re-fined screening to completing treatment and 25 days for early colorectal cancer patients . [ Conclusion] The model and method adopted in Wujing community is helpful to improve the compliance of colorectal cancer screening .

Outcome of transcatheter closure of perimembranous ventricular septal defect with modified double-disk occluder device / 中华心血管病杂志

<p><b>OBJECTIVE</b>To evaluate the efficacy and adverse effects of transcatheter closure of perimembranous ventricular septal defect (pmVSD) with modified double-disk occluder device (MDVO).</p><p><b>METHODS</b>Clinical data including clinical examination, electrocardiography daily after the procedure for a week, chest-X-rays and TTE before discharge and at 3-5 days after the procedure were analyzed from 604 patients underwent percutaneous closure of a pmVSD with MDVO at our department between December 2001 and December 2008.</p><p><b>RESULTS</b>Procedure was successful in 576 out of 604 patients (95.4%) and 583 VSD occluders were placed. Endocarditis, thromboembolism, or deaths were not observed after procedure. Conduction block occurred in 81 patients (56 RBBB, 14 LBBB) and transient nonparoxysmal ventricular tachycardia in 31 patients after the procedure. Complete heart block occurred in 11 patients, 9 of them recovered in 3 weeks, permanent pacemaker was implanted in 2 patients (one had transient III degrees AVB before the procedure, the other underwent simultaneous closure of ventricular septal defect and atrial septal defect). Trivial/small residual shunts were found in 69 patients (12.0%). The residual shunts disappeared in 31 patients and remained unchanged in 38 patients (6.6%) 7 days after procedures. Aortic regurgitation developed in 5 patients (2 trivial/small, 3 small/moderate), and tricuspid regurgitation was present in 35 patients (32 trivial/small, 3 moderate). Five patients developed haemolysis (device retrieved via catheter in 1 patient due to persistent haemolysis, the other 4 patients recovered 3-14 days post procedure). Pseudoaneurysm of femoral artery occurred in 1 patient, and disappeared by pressure dressing. Device was successfully replaced in 2 patients with either device embolization (n = 1) or device misplacement (n = 1) after device retrieval by catheter.</p><p><b>CONCLUSION</b>It is safe and effective to close congenital perimembranous ventricular septal defect with domestic-made occluder device.</p>

Study on transcatheter ASD occlusion using modified atrial septal defect occluder with no stainless steel screw in canine model / 介入放射学杂志

Objective To evaluate the safety,biocompatibility and efficacy of transcatheter closure of atrial septal defect(ASD)with no stainless-steel-screw occluder in canine model.Methods The device was constructed from superelastic Nitinol wires tightly woven into two flat disks and sewed with polyester fibers inside,with a pliable loop on the right-atrial-disk of the device,connecting to the delivery cable.ASD was created by transcatheter puncture and balloon dilatation and then closed by occluder under fluoroscopy in the catheterization laboratory.The location and the influence of the implanted device on function of tricuspid valve and mitral valve were evaluated by echocardiography.At 1,2,3 and 6 months after the operation,the animals were killed and autopsy was conducted.Results Eight dogs with puncture-produced ASD underwent ASD closing procedure successfully.The occluder showed no influence on the function of MV and AV demonstrated by echocardiogram.The two disks of the implanted device were covered with a smooth intact neogenesis layer in all dogs.Endocardial cells fully covered the surface of the two disk without inflammating reaction 3 months later. There was no evidence of corrosion on the surface of the nitinol wire removed from the dog after 6 months.Light microscopic examination of the liver,kidney,lung and spleen showed no evidence of embolization and inflammation.Conclusion Transcatheter ASD occlusion with new-type occluder is safe,feasible,effective and good biocompatibility with a good prospective clinical application.